Tsfg, LLC Novartis Ag Transaction History

Tsfg, LLC

$428 Million
Q2 2024

A detailed history of Tsfg, LLC transactions in Novartis Ag stock. As of the latest transaction made, Tsfg, LLC holds 50 shares of NVS stock, worth $5,780. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 50 -0.0%

Holding current value

$5,780

Previous $5,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	BUY	$95.27 - $108.47 $1,429 - $1,627	15 Added 42.86%	50 $5,000
Q4 2023 Jan 23, 2024	SELL	$92.27 - $101.54 $9,319 - $10,255	-101 Reduced 74.26%	35 $4,000
Q4 2022 Jan 19, 2023	BUY	$75.55 - $92.52 $2,644 - $3,238	35 Added 34.65%	136 $12,000
Q3 2022 Oct 20, 2022	BUY	$74.61 - $87.26 $74 - $87	1 Added 1.0%	101 $8,000
Q2 2021 Jul 19, 2021	SELL	$85.24 - $94.15 $1,278 - $1,412	-15 Reduced 13.04%	100 $9,000
Q1 2021 Apr 14, 2021	SELL	$83.5 - $98.47 $10,771 - $12,702	-129 Reduced 52.87%	115 $10,000
Q4 2020 Jan 20, 2021	BUY	$78.07 - $94.43 $3,357 - $4,060	43 Added 21.39%	244 $23,000
Q3 2020 Oct 06, 2020	SELL	$82.14 - $91.0 $657 - $728	-8 Reduced 3.83%	201 $17,000
Q2 2020 Jul 07, 2020	SELL	$80.93 - $91.1 $10,682 - $12,025	-132 Reduced 38.71%	209 $18,000
Q1 2020 Apr 08, 2020	BUY	$70.67 - $99.01 $2,261 - $3,168	32 Added 10.36%	341 $28,000
Q4 2019 Jan 27, 2020	BUY	$84.35 - $95.37 $12,652 - $14,305	150 Added 94.34%	309 $29,000
Q3 2019 Jan 27, 2020	BUY	$85.54 - $94.26 $256 - $282	3 Added 1.92%	159 $14,000
Q2 2019 Jan 27, 2020	BUY	$75.4 - $92.8 $1,055 - $1,299	14 Added 9.86%	156 $14,000
Q1 2019 Jan 27, 2020	BUY	$75.32 - $86.15 $10,695 - $12,233	142 New	142 $14,000

Others Institutions Holding NVS

# of Institutions

1,426

Shares Held

138M

Call Options Held

1.48M

Put Options Held

1.54M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $249B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tsfg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tsfg, LLC with notifications on news.

Account